Herbal Nanomedicines Market Research Report by Type (Polymeric Herbal Nanoparticles, Solid Lipid Nanoparticles, Phytosomes, Nano-Micelles, Self-nano Emulsifying Drug Delivery System, Nanofibers, Others), by Source (Ginseng, Turmeric, Aloe Vera, Ginger, Others), by Application (Cancer, Cardiovascular Diseases, Neurological Disorders, Others), by Region (North America, Europe, Asia Pacific, Rest of the World) Forecast till 2032 Market Overview The global herbal nanomedicines market is projected to reach USD 14,946.60 million by 2032, expanding at a CAGR of 8.55% by the end of 2032. Herbal nanomedicines are therapeutic formulations that combine herbal extracts with nanotechnology to enhance their bioavailability, stability, and targeted delivery. By encapsulating plant-based compounds into nanoparticles, these medicines improve effectiveness and reduce side effects, making traditional remedies more efficient in modern healthcare. One of the most significant factors that has led to the global market's increase is the growing demand for natural and herbal-based nanomedicines. This trend is largely fuelled by the fact that these products are effective and have minimal side effects when compared to conventional drugs. Nanotechnology is helping to improve the solubility, stability, and bioavailability of plant-derived compounds such as curcumin and resveratrol, thus making them suitable for the treatment of chronic conditions. The likes of Herbalife and Nanoceutical Solutions are utilizing innovative nano-formulations to not only but global adoption of holistic, safer, and highly efficient treatment options to accelerate the practice. Key Company Development Indena S.p.A. goes after creating new basic principles of nature medicine for health food, personal care, and pharmaceutical applications. The company is very much into advanced research and production technologies with the purpose of bringing the needed safety and quality to natural ingredients while always seeking to improve the plant-based innovation with excellence. This tactic leads not only to merging its positions in pharmaceuticals and nutraceuticals but also to adding “value difference” to its global partners. Major Players Key competitors in the global herbal nanomedicines market are Oneplanet Nutrition, Indena S.p.A., Codeage LLC, Nutriherbs, Basic Brands Inc., Nanoceutical Solutions, Vibdrugs Biosciences, OIC New, Herbalife Ltd, and Evolu Research. Report Attribute Details Market Size 2022 USD 5,981.97 Million Market Size 2032 USD 14,946.60 Million CAGR (2023-2032) 8.55% Base Year 2022 Market Forecast Period 2023-2032 Market Segmentations By Type: Polymeric Herbal Nanoparticles - 8.78%, Solid Lipid Nanoparticles - 9.36%. By Source: Ginseng - 8.95%, Turmeric - 9.71%. By Application: Cancer - 9.86%, Cardiovascular Diseases - 7.41%. Regional Insights North America is one of the leading regions in the herbal nanomedicines market, where the market was worth USD 2,319.81 million in 2022 and is expected to grow at a 7.49% CAGR. With the U.S. at USD 1,910.59 million and Canada at USD 409.21 million, North America leads the market owing to advanced healthcare infrastructure and strong consumer preference for herbal nanomedicine. The European market stood at USD 1,575.65 million in 2022 and has been forecast to grow at a CAGR of 8.92%. Rooted with outstanding healthcare systems, consumers' high confidence in herbal products, and a regulatory framework that supports the growth, Europe is going to have a steady rise in the herbal nanomedicine market. Germany (USD 396 million), the UK (USD 294.45 million), and France (USD 250.55 million) drive Europe’s market through regulatory support and rising demand for plant-based therapies. The Asia-Pacific region recorded USD 1,392.60 million in 2022 and is expected to have the highest growth rate with a CAGR of 10.53%. China (USD 340.53 million), Japan (USD 293.81 million), and India (USD 241.04 million) highlight APAC’s rapid adoption, backed by strong traditional medicine practices and growing nanotech integration. Besides India and China, other countries in the region are taking advantage of the traditional herbal medicine that is several hundred years old and combining it with nanotechnology. The Rest of the World market stood at USD 693.91 million in 2022, growing at a 6.47% CAGR. Latin America, the Middle East, and Africa are witnessing rising awareness and investments in herbal-based treatments. However, a lack of skilled workforce and political instability may hinder steady expansion.

TABLE OF CONTENTS 1 EXECUTIVE SUMMARY 16 2 MARKET INTRODUCTION 18 2.1 DEFINITION 18 2.2 SCOPE OF THE STUDY 18 2.3 RESEARCH OBJECTIVE 18 2.4 MARKET STRUCTURE 18 3 RESEARCH METHODOLOGY 19 3.1 OVERVIEW 19 3.2 DATA FLOW 21 3.2.1 DATA MINING PROCESS 21 3.3 PURCHASED DATABASE: 22 3.4 SECONDARY SOURCES: 23 3.4.1 SECONDARY RESEARCH DATA FLOW: 24 3.5 PRIMARY RESEARCH: 25 3.5.1 PRIMARY RESEARCH DATA FLOW: 26 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED 27 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE 27 3.6 APPROACHES FOR MARKET SIZE ESTIMATION: 28 3.6.1 REVENUE ANALYSIS APPROACH 28 3.7 DATA FORECASTING 29 3.7.1 DATA FORECASTING TYPE 29 3.8 DATA MODELING 30 3.8.1 MICROECONOMIC FACTOR ANALYSIS: 30 3.8.2 DATA MODELING: 31 3.9 TEAMS AND ANALYST CONTRIBUTION 33 4 MARKET DYNAMICS 35 4.1 INTRODUCTION 35 4.2 DRIVERS 36 4.2.1 INCREASING DEMAND FOR NATURAL AND HERBAL-BASED NANOMEDICINE 36 4.2.2 GROWING GERIATRIC POPULATION 36 4.3 RESTRAINTS 37 4.3.1 LACK OF AWARENESS ASSOCIATED WITH HERBAL NANOMEDICINE 37 4.4 OPPORTUNITY 39 4.4.1 ONGOING RESEARCH AND CLINICAL TRIALS ON HERBAL NANOMEDICINE 39 5 MARKET FACTOR ANALYSIS 40 5.1 PORTER'S FIVE FORCES MODEL 40 5.1.1 THREAT OF NEW ENTRANTS 40 5.1.2 BARGAINING POWER OF SUPPLIERS 41 5.1.3 THREAT OF SUBSTITUTES 41 5.1.4 BARGAINING POWER OF BUYERS 41 5.1.5 INTENSITY OF RIVALRY 41 5.2 IMPACT OF COVID-19 ON THE GLOBAL HERBAL NANOMEDICINE MARKET 42 5.3 TRENDS IN HERBAL NANOMEDICINES 42 5.3.1 BENEFITS OF NANOSIZING 42 5.3.2 COMBINATION THERAPY 42 5.3.3 SAFETY AND BIOCOMPATIBILITY 43 5.3.4 CLINICAL TRIALS AND COMMERCIALIZATION 43 6 GLOBAL HERBAL NANOMEDICINE MARKET, BY TYPE 45 6.1 OVERVIEW 45 6.2 POLYMERIC HERBAL NANOPARTICLES 48 6.3 SOLID LIPID NANOPARTICLES 48 6.4 PHYTOSOMES 49 6.5 NANO-MICELLES 49 6.6 SELF-NANO EMULSIFYING DRUG DELIVERY SYSTEM 50 6.7 NANOFIBERS 50 6.8 OTHERS 51 7 GLOBAL HERBAL NANOMEDICINE MARKET, BY SOURCE 52 7.1 OVERVIEW 52 7.2 GINSENG 54 7.3 TURMERIC 55 7.4 ALOE VERA 55 7.5 GINGER 56 7.6 OTHERS 56 8 GLOBAL HERBAL NANOMEDICINE MARKET, BY APPLICATION 57 8.1 OVERVIEW 57 8.2 CANCER 60 8.3 CARDIOVASCULAR DISEASES 61 8.4 NEUROLOGICAL DISORDERS 61 8.5 OTHERS 62 9 GLOBAL HERBAL NANOMEDICINE MARKET, BY REGION 63 9.1 OVERVIEW 63 9.2 NORTH AMERICA 65 9.2.1 US 69 9.2.2 CANADA 70 9.3 EUROPE 72 9.3.1 GERMANY 76 9.3.2 FRANCE 77 9.3.3 UK 79 9.3.4 ITALY 80 9.3.5 SPAIN 82 9.3.6 REST OF EUROPE 83 9.4 ASIA-PACIFIC 85 9.4.1 CHINA 89 9.4.2 INDIA 90 9.4.3 JAPAN 92 9.4.4 AUSTRALIA 93 9.4.5 SOUTH KOREA 95 9.4.6 REST OF ASIA-PACIFIC 96 9.5 REST OF THE WORLD 98 9.5.1 MIDDLE EAST & AFRICA 102 9.5.2 SOUTH AMERICA 103 10 COMPETITIVE LANDSCAPE 106 10.1 INTRODUCTION 106 10.2 MARKET SHARE ANALYSIS, 2022 106 10.3 COMPETITOR DASHBOARD 107 10.4 PUBLIC PLAYERS STOCK SUMMARY 108 10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL 108 11 COMPANY PROFILES 109 11.1 EVOLU RESEARCH 109 11.1.1 COMPANY OVERVIEW 109 11.1.2 FINANCIAL OVERVIEW 109 11.1.3 PRODUCTS OFFERED 109 11.1.4 KEY DEVELOPMENTS 109 11.1.5 KEY STRATEGIES 109 11.2 CODEAGE LLC 110 11.2.1 COMPANY OVERVIEW 110 11.2.2 FINANCIAL OVERVIEW 110 11.2.3 PROUDCTS OFFERED 110 11.2.4 KEY DEVELOPMENTS 110 11.2.5 SWOT ANALYSIS 111 11.2.6 KEY STRATEGIES 111 11.3 NUTRIHERBS 112 11.3.1 COMPANY OVERVIEW 112 11.3.2 FINANCIAL OVERVIEW 112 11.3.3 PRODUCTS OFFERED 112 11.3.4 KEY DEVELOPMENTS 112 11.3.5 KEY STRATEGIES 112 11.4 BASIC BRANDS INC. 113 11.4.1 COMPANY OVERVIEW 113 11.4.2 FINANCIAL OVERVIEW 113 11.4.3 PRODUCTS OFFERED 113 11.4.4 KEY DEVELOPMENTS 113 11.4.5 KEY STRATEGIES 113 11.5 HERBALIFE INTERNATIONAL OF AMERICA, INC. 114 11.5.1 COMPANY OVERVIEW 114 11.5.2 FNANCIAL OVERVIEW 115 11.5.3 SERVICES OFFERED 115 11.5.4 KEY DEVELOPMENTS 115 11.5.5 SWOT ANALYSIS 116 11.5.6 KEY STRATEGIES 116 11.6 INDENA S.P.A 117 11.6.1 COMPANY OVERVIEW 117 11.6.2 FINANCIAL OVERVIEW 118 11.6.3 PRODUCTS OFFERED 118 11.6.4 KEY DEVELOPMENTS 118 11.6.5 SWOT ANALYSIS 119 11.6.6 KEY STRATEGIES 119 11.7 NANOCEUTICAL SOLUTIONS 120 11.7.1 COMPANY OVERVIEW 120 11.7.2 FINANCIAL OVERVIEW 120 11.7.3 PRODUCTS OFFERED 120 11.7.4 KEY DEVELOPMENTS 120 11.7.5 KEY STRATEGY 121 11.8 VIBDRUGS BIOSCIENCES 121 11.8.1 COMPANY OVERVIEW 121 11.8.2 FINANCIAL OVERVIEW 121 11.8.3 PRODUCTS OFFERED 121 11.8.4 KEY DEVELOPMENTS 122 11.8.5 KEY STRATEGIES 122 11.9 ONE PLANET NUTRITION 122 11.9.1 COMPANY OVERVIEW 122 11.9.2 FINANCIAL OVERVIEW 122 11.9.3 PRODUCTS OFFERED 123 11.9.4 KEY DEVELOPMENTS 123 11.9.5 SWOT ANALYSIS 124 11.9.6 KEY STRATEGY 124 11.10 OIC NEW 125 11.10.1 COMPANY OVERVIEW 125 11.10.2 FINANCIAL OVERVIEW 126 11.10.3 PRODUCTS OFFERED 126 11.10.4 KEY DEVELOPMENTS 126 11.10.5 SWOT ANALYSIS 127 11.10.6 KEY STRATEGIES 127 12 DATA CITATIONS 128

LIST OF TABLES TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 31 TABLE 2 GLOBAL HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD MILLION) 47 TABLE 3 GLOBAL HERBAL NANOMEDICINE MARKET, FOR POLYMERIC HERBAL NANOPARTICLES, BY REGION, 2019–2032 (USD MILLION) 48 TABLE 4 GLOBAL HERBAL NANOMEDICINE MARKET, FOR SOLID LIPID NANOPARTICLES, BY REGION, 2019–2032 (USD MILLION) 48 TABLE 5 GLOBAL HERBAL NANOMEDICINE MARKET, FOR PHYTOSOMES, BY REGION, 2019–2032 (USD MILLION) 49 TABLE 6 GLOBAL HERBAL NANOMEDICINE MARKET, FOR NANO-MICELLES, BY REGION, 2019–2032 (USD MILLION) 49 TABLE 7 GLOBAL HERBAL NANOMEDICINE MARKET, FOR SELF-NANO EMULSIFYING DRUG DELIVERY SYSTEM, BY REGION, 2019–2032 (USD MILLION) 50 TABLE 8 GLOBAL HERBAL NANOMEDICINE MARKET, FOR NANOFIBERS, BY REGION, 2019–2032 (USD MILLION) 50 TABLE 9 GLOBAL HERBAL NANOMEDICINE MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION) 51 TABLE 10 GLOBAL HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD MILLION) 53 TABLE 11 GLOBAL HERBAL NANOMEDICINE MARKET, FOR GINSENG, BY REGION, 2019–2032 (USD MILLION) 54 TABLE 12 GLOBAL HERBAL NANOMEDICINE MARKET, FOR TURMERIC, BY REGION, 2019–2032 (USD MILLION) 55 TABLE 13 GLOBAL HERBAL NANOMEDICINE MARKET, FOR ALOE VERA, BY REGION, 2019–2032 (USD MILLION) 55 TABLE 14 GLOBAL HERBAL NANOMEDICINE MARKET, FOR GINGER, BY REGION, 2019–2032 (USD MILLION) 56 TABLE 15 GLOBAL HERBAL NANOMEDICINE MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION) 56 TABLE 16 GLOBAL HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 59 TABLE 17 GLOBAL HERBAL NANOMEDICINE MARKET, FOR CANCER, BY REGION, 2019–2032 (USD MILLION) 60 TABLE 18 GLOBAL HERBAL NANOMEDICINE MARKET, FOR CARDIOVASCULAR DISEASES, BY REGION, 2019–2032 (USD MILLION) 61 TABLE 19 GLOBAL HERBAL NANOMEDICINE MARKET, FOR NEUROLOGICAL DISORDERS, BY REGION, 2019–2032 (USD MILLION) 61 TABLE 20 GLOBAL HERBAL NANOMEDICINE MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION) 62 TABLE 21 GLOBAL HERBAL NANOMEDICINE MARKET, BY REGION, 2019–2032 (USD MILLION) 63 TABLE 22 NORTH AMERICA HERBAL NANOMEDICINE MARKET, BY COUNTRY, 2019–2032 (USD MILLION) 66 TABLE 23 NORTH AMERICA: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD MILLION) 67 TABLE 24 NORTH AMERICA: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD MILLION) 68 TABLE 25 NORTH AMERICA: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 68 TABLE 26 US: HERBAL NANOMEDICINE MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 69 TABLE 27 US: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD MILLION) 69 TABLE 28 US: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 70 TABLE 29 CANADA: HERBAL NANOMEDICINE MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 70 TABLE 30 CANADA: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD MILLION) 71 TABLE 31 CANADA: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 71 TABLE 32 EUROPE HERBAL NANOMEDICINE MARKET, BY COUNTRY, 2019–2032 (USD MILLION) 73 TABLE 33 EUROPE: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD MILLION) 74 TABLE 34 EUROPE: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD MILLION) 75 TABLE 35 EUROPE: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 75 TABLE 36 GERMANY: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD MILLION) 76 TABLE 37 GERMANY: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD MILLION) 76 TABLE 38 GERMANY: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 77 TABLE 39 FRANCE: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD MILLION) 77 TABLE 40 FRANCE: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD MILLION) 78 TABLE 41 FRANCE: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 78 TABLE 42 UK: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD MILLION) 79 TABLE 43 UK: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD MILLION) 79 TABLE 44 UK: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 80 TABLE 45 ITALY: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD MILLION) 80 TABLE 46 ITALY: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD MILLION) 81 TABLE 47 ITALY: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 81 TABLE 48 SPAIN: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD MILLION) 82 TABLE 49 SPAIN: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD MILLION) 82 TABLE 50 SPAIN: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 83 TABLE 51 REST OF EUROPE: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD MILLION) 83 TABLE 52 REST OF EUROPE: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD MILLION) 84 TABLE 53 REST OF EUROPE: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 84 TABLE 54 ASIA-PACIFIC HERBAL NANOMEDICINE MARKET, BY COUNTRY, 2019–2032 (USD MILLION) 86 TABLE 55 ASIA-PACIFIC: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD MILLION) 87 TABLE 56 ASIA-PACIFIC: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD MILLION) 88 TABLE 57 ASIA-PACIFIC: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 88 TABLE 58 CHINA: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD MILLION) 89 TABLE 59 CHINA: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD MILLION) 89 TABLE 60 CHINA: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 90 TABLE 61 INDIA: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD MILLION) 90 TABLE 62 INDIA: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD MILLION) 91 TABLE 63 INDIA: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 91 TABLE 64 JAPAN: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD MILLION) 92 TABLE 65 JAPAN: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD MILLION) 92 TABLE 66 JAPAN: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 93 TABLE 67 AUSTRALIA: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD MILLION) 93 TABLE 68 AUSTRALIA: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD MILLION) 94 TABLE 69 AUSTRALIA: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 94 TABLE 70 SOUTH KOREA: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD MILLION) 95 TABLE 71 SOUTH KOREA: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD MILLION) 95 TABLE 72 SOUTH KOREA: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 96 TABLE 73 REST OF ASIA-PACIFIC: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD MILLION) 96 TABLE 74 REST OF ASIA-PACIFIC: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD MILLION) 97 TABLE 75 REST OF ASIA-PACIFIC: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 97 TABLE 76 REST OF THE WORLD HERBAL NANOMEDICINE MARKET, BY COUNTRY, 2019–2032 (USD MILLION) 99 TABLE 77 REST OF THE WORLD: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD MILLION) 100 TABLE 78 REST OF THE WORLD: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD MILLION) 101 TABLE 79 REST OF THE WORLD: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 101 TABLE 80 MIDDLE EAST & AFRICA: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD MILLION) 102 TABLE 81 MIDDLE EAST & AFRICA: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD MILLION) 102 TABLE 82 MIDDLE EAST & AFRICA: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 103 TABLE 83 SOUTH AMERICA: HERBAL NANOMEDICINE MARKET, BY TYPE, 2019–2032 (USD MILLION) 103 TABLE 84 SOUTH AMERICA: HERBAL NANOMEDICINE MARKET, BY SOURCE, 2019–2032 (USD MILLION) 104 TABLE 85 SOUTH AMERICA: HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 104 TABLE 86 EVOLU RESEARCH: PRODUCTS OFFERED 109 TABLE 87 CODEAGE LLC: PRODUCT OFFERED 110 TABLE 88 NUTRIHERBS: PRODUCT OFFERED 112 TABLE 89 BASIC BRANDS INC.: PRODUCTS OFFERED 113 TABLE 90 HERBALIFE INTERNATIONAL OF AMERICA, INC.: PRODUCT OFFERED 115 TABLE 91 INDENA S.P.A. PRODUCTS OFFERED 118 TABLE 92 NANOCEUTICAL SOLUTIONS: PRODUCTS OFFERED 120 TABLE 93 VIBDRUGS BIOSCIENCES: PRODUCT OFFERED 121 TABLE 94 ONE PLANET NUTRITION: PRODUCTS OFFERED 123 TABLE 95 OIC NEW: PRODUCT OFFERED 126 LIST OF FIGURES FIGURE 1 GLOBAL HERBAL NANOMEDICINE MARKET: STRUCTURE 18 FIGURE 2 GLOBAL HERBAL NANOMEDICINE MARKET: MARKET GROWTH FACTOR ANALYSIS (2022-2032) 35 FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032) 37 FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032) 38 FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL HERBAL NANOMEDICINE MARKET 40 FIGURE 6 GLOBAL HERBAL NANOMEDICINE MARKET, TYPE SEGMENT, 2022 & 2032 (USD MILLION) 46 FIGURE 7 GLOBAL HERBAL NANOMEDICINE MARKET, BY TYPE, 2022 & 2032 (USD MILLION) 46 FIGURE 8 GLOBAL HERBAL NANOMEDICINE MARKET SHARE (%), BY TYPE, 2022 47 FIGURE 9 GLOBAL HERBAL NANOMEDICINE MARKET, SOURCE SEGMENT, 2022 & 2032 (USD MILLION) 52 FIGURE 10 GLOBAL HERBAL NANOMEDICINE MARKET, BY SOURCE, 2022 & 2032 (USD MILLION) 53 FIGURE 11 GLOBAL HERBAL NANOMEDICINE MARKET SHARE (%), BY SOURCE, 2022 54 FIGURE 12 GLOBAL HERBAL NANOMEDICINE MARKET, APPLICATION SEGMENT, 2022 & 2032 (USD MILLION) 58 FIGURE 13 GLOBAL HERBAL NANOMEDICINE MARKET, BY APPLICATION, 2022 & 2032 (USD MILLION) 59 FIGURE 14 GLOBAL HERBAL NANOMEDICINE MARKET SHARE (%), BY APPLICATION, 2022 60 FIGURE 15 GLOBAL HERBAL NANOMEDICINE MARKET, BY REGION, 2022 & 2032 (USD MILLION) 63 FIGURE 16 GLOBAL HERBAL NANOMEDICINE MARKET SHARE, BY REGION, 2022 (% SHARE) 64 FIGURE 17 NORTH AMERICA MARKET ANALYSIS: HERBAL NANOMEDICINE MARKET, 2019-2032 (USD MILLION) 65 FIGURE 18 NORTH AMERICA HERBAL NANOMEDICINE MARKET, BY COUNTRY, 2022 & 2032 (USD MILLION) 66 FIGURE 19 NORTH AMERICA HERBAL NANOMEDICINE MARKET, BY COUNTRY, 2022 (% SHARE) 67 FIGURE 20 EUROPE MARKET ANALYSIS: HERBAL NANOMEDICINE MARKET, 2019-2032 (USD MILLION) 72 FIGURE 21 EUROPE HERBAL NANOMEDICINE MARKET, BY COUNTRY, 2022 & 2032 (USD MILLION) 73 FIGURE 22 EUROPE HERBAL NANOMEDICINE MARKET, BY COUNTRY, 2022 (% SHARE) 74 FIGURE 23 ASIA-PACIFIC MARKET ANALYSIS: HERBAL NANOMEDICINE MARKET, 2019-2032 (USD MILLION) 85 FIGURE 24 ASIA-PACIFIC HERBAL NANOMEDICINE MARKET, BY COUNTRY, 2022 & 2032 (USD MILLION) 86 FIGURE 25 ASIA-PACIFIC HERBAL NANOMEDICINE MARKET, BY COUNTRY, 2022 (% SHARE) 87 FIGURE 26 REST OF THE WORLD MARKET ANALYSIS: HERBAL NANOMEDICINE MARKET, 2019-2032 (USD MILLION) 98 FIGURE 27 REST OF THE WORLD HERBAL NANOMEDICINE MARKET, BY COUNTRY, 2022 & 2032 (USD MILLION) 99 FIGURE 28 REST OF THE WORLD HERBAL NANOMEDICINE MARKET, BY COUNTRY, 2022 (% SHARE) 100 FIGURE 29 GLOBAL HERBAL NANOMEDICINE MARKET PLAYERS: COMPETITIVE ANALYSIS, 2022 106 FIGURE 30 COMPETITOR DASHBOARD: GLOBAL HERBAL NANOMEDICINE MARKET 107 FIGURE 31 CODEAGE LLC: SWOT ANALYSIS 111 FIGURE 32 HERBALIFE INTERNATIONAL OF AMERICA, INC.: FINANCIAL OVERVIEW 115 FIGURE 33 HERBALIFE INTERNATIONAL OF AMERICA, INC.: SWOT ANALYSIS 116 FIGURE 34 INDENA S.P.A.: SWOT ANALYSIS 119 FIGURE 35 ONE PLANET NUTRITION: SWOT ANALYSIS 124 FIGURE 36 OIC NEW: SWOT ANALYSIS 127

Single User Price	$4,950 USD
Multi User Licence (up to 10 users)	$5,950 USD
Enterprisewide Price (Global Site License)	$7,250 USD

授權報價

報告摘要

提及公司

同分類最新報告（醫療與生命科學）